Pancreatic Cancer

Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.

La tasa de supervivencia a cinco años para el cáncer de páncreas es solo del 10,8 %. Aquí hay cinco cosas que todos deberían saber sobre este cáncer mortal.

A recent study provides support for Mayo Clinic's use of positron emission tomography (PET) to guide pancreatic cancer treatment decisions.

A new Mayo Clinic study finds 1 in 6 people with pancreatic cancer harbor inherited genetic mutations.

Physician assistant Casey Swanson responds to a question about cancer risk and genetic testing for a BRCA2 mutation.

The five-year survival rate for pancreatic cancer is just 10.8%. Here are five things everyone should know about this deadly cancer.

Mayo Clinic researchers have opened up a promising front in their search for new ways to increase the effectiveness of chemotherapy against pancreatic adenocarcinoma, one[...]

Michael B. Wallace, M.D., a gastroenterologist at Mayo Clinic in Jacksonville, Florida, discusses his research on the early detection of pancreatic cancer.

Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.

A new Mayo Clinic study suggests that some patients with pancreatic cancer could increase survival with adjustments to their chemotherapy regimen before surgery. Historically, most[...]